WallStreetZenWallStreetZen

NASDAQ: ABVC
Abvc Biopharma Inc Earnings & Revenue

ABVC past revenue growth

How has ABVC's revenue growth performed historically?
Company
-84.28%
Industry
148.97%
Market
17.57%
ABVC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABVC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ABVC earnings and revenue history

Current Revenue
$152.4k
Current Earnings
-$10.5M
Current Profit Margin
-6,898.7%

ABVC Return on Equity

Current Company
-224%
Current Industry
-63.5%
Current Market
188%
ABVC's Return on Equity (-224%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ABVC announces earnings.

ABVC Return on Assets

Current Company
-82.3%
Current Industry
2.9%
ABVC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABVC Return on Capital Employed

Current Company
-90.73%
Current Industry
19.5%
ABVC has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABVC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABVC$152.43k-$7.74M-$10.52M-31.73%N/A
GRTX$0.00-$47.41M-$59.08MN/AN/A
IMNN$0.00-$19.88M-$19.51M-100.00%N/A
BNOX$14.50kN/A-$20.40M-91.52%+261.25%
ONVO$242.00k-$18.82M-$19.09M-41.45%N/A

ABVC earnings dates

Next earnings date
May 13, 2024

Abvc Biopharma Earnings & Revenue FAQ

What were ABVC's earnings last quarter?

On Invalid Date, Abvc Biopharma (NASDAQ: ABVC) reported Q4 2023 earnings per share (EPS) of -$0.35, up 76.35% year over year. Total Abvc Biopharma earnings for the quarter were -$3.11 million. In the same quarter last year, Abvc Biopharma's earnings per share (EPS) was -$1.48.

If you're new to stock investing, here's how to buy Abvc Biopharma stock.

What was ABVC's earnings growth in the past year?

As of Q2 2024, Abvc Biopharma's earnings has grown year over year. Abvc Biopharma's earnings in the past year totalled -$10.52 million.

What is ABVC's earnings date?

Abvc Biopharma's earnings date is Invalid Date. Add ABVC to your watchlist to be reminded of ABVC's next earnings announcement.

What was ABVC's revenue last quarter?

On Invalid Date, Abvc Biopharma (NASDAQ: ABVC) reported Q4 2023 revenue of $2.17 thousand up 99.63% year over year. In the same quarter last year, Abvc Biopharma's revenue was $588.99 thousand.

What was ABVC's revenue growth in the past year?

As of Q2 2024, Abvc Biopharma's revenue has grown -84.28% year over year. This is 233.25 percentage points lower than the US Biotechnology industry revenue growth rate of 148.97%. Abvc Biopharma's revenue in the past year totalled $152.43 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.